Sangamo Therapeutics
Sangamo Therapeutics Logo
About Sangamo Therapeutics
Sangamo Therapeutics Inc is a biotechnology company specializing in the research, development, and commercialization of genomic medicines. The company leverages proprietary gene therapy, gene editing, cell therapy, and gene regulation platforms, including its zinc finger technology, to develop transformative treatments for patients with serious genetic and neurological diseases. Sangamo's clinical pipeline includes gene therapies for Fabry disease and hemophilia A, as well as cell therapies for immune-mediated conditions and sickle cell disease. The company also advances preclinical programs targeting autoimmune disorders and neurological diseases. Sangamo collaborates with leading pharmaceutical and biotechnology partners to accelerate the development and delivery of innovative genomic medicines. Founded in 1995 and headquartered in Richmond, California, Sangamo is committed to pioneering genetic cures for patients worldwide.
Address
501 Canal Blvd,
Richmond, 94804
United States
Year founded
1995
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
